Delivery Order SPE2DE24D0021-SPE2D625F7DA0
- Not listed
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $2,098.08 fixed-price delivery order contract to Fisher Scientific Company L.L.C. for the procurement of 4565516584! SUPERSCRIPT IV VILO MIX 50RXN. This contract does not utilize a set-aside designation. Fisher Scientific is a large for-profit limited liability company that provides a wide range of laboratory supplies, instruments, and diagnostic testing kits to support research, testing, and healthcare initiatives across the...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract valued at $5,980.92 on April 24, 2025, by the Medical Supply Chain division of the Defense agency. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, covers the procurement of SS III One-Step Hi Fi 100 Rxn products and is scheduled for completion by May 7, 2025. Performance will be executed at Fisher Scientific's location in Pittsburgh, Pennsylvania. This award represents a...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $1,144.94 by the Defense Medical Supply Chain on August 6, 2025, for the supply identified as "SUPERSCRIPT IV FIRSTSTRAND SYN." The contract, which is classified as a child award under a larger vehicle, carries an ultimate completion date of August 20, 2025, and will be performed in Pittsburgh, Pennsylvania. No set-aside designation was applied to this procurement, indicating open competition. Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract valued at $1,685.23 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 10, 2025. The contract, designated as SUPERSCRIPT IV FIRSTSTRAND SYN (4569615216), is structured as a fixed-price delivery order with economic price adjustment provisions and utilizes no set-aside designation, reflecting open competition. Performance of this contract will take place at Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,521.03 on September 26, 2025, for RNA isolation and purification products to support the Defense Department's Medical Supply Chain. The contract features fixed-price pricing with economic price adjustment provisions and will be completed by October 10, 2025, with performance at the vendor's Pittsburgh, Pennsylvania location. This award represents a child contract with no small business set-aside designation, reflecting...
- This federal contract award, valued at $5,328.00, was issued by the Medical Supply Chain, a component of the Defense agency, to Fisher Scientific Company L.L.C., a for-profit limited liability company and major supplier of scientific products, equipment, and services to federal government agencies. The contract is a Delivery Order under the Multiple Award Schedule (MAS) contract vehicle, with a Fixed Price with Economic Price Adjustment pricing type and an ultimate completion date of March 31,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,485.00 for SSIII 1-Step QRT-PCR 100 supplies under a fixed-price contract with economic price adjustment provisions. The contract was awarded on June 2, 2025, with an ultimate completion date of June 24, 2025, and will be performed in Pittsburgh, Pennsylvania. This award was issued by the Medical Supply Chain division within the Department of Defense and represents an open competition procurement with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $34,334.30 on August 22, 2025, by the Medical Supply Chain, a defense-focused federal agency. The delivery order, designated as "PRCRPLX MS CYTOKINE + CH 96 TS," procures specialized cytokine and chemistry testing supplies for performance at Fisher Scientific's Pittsburgh, Pennsylvania location, with an ultimate completion date of September 2, 2025. This award represents a child contract under a...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,789.98 for RNA isolation and purification products under a fixed price contract with economic price adjustment provisions. The award was issued on August 6, 2025, with an ultimate completion date of August 13, 2025, and will be performed in Pittsburgh, PA. The contract represents an open competition award with no set-aside designation to the Medical Supply Chain, a defense-focused federal agency. This delivery...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 7, 2025, for TaqMan Fast Virus 1-Step MMix, a molecular diagnostic reagent used in viral testing applications. This fixed-price contract with economic price adjustment has a ceiling value of $4,165.58 and is scheduled for completion by August 19, 2025. The work will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating it was issued under an existing contract vehicle, likely...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F7DA0Delivery Order
Fisher Scientific Company L.L.C. has been awarded a $2,622.45 delivery order by the Department of Defense's Medical Supply Chain for the procurement of SUPERSCRIPT IV VILO MIX 50RXN, a specialized molecular biology reagent used in research and diagnostics. This fixed-price contract with economic price adjustment authority is structured as a child contract under a larger vehicle and carries an ultimate completion date of July 30, 2025. The award was made on July 16, 2025, without a set-aside designation, reflecting Fisher Scientific's demonstrated capability to compete effectively in open federal procurement. Performance will take place at Fisher Scientific's Pittsburgh, Pennsylvania facility. Fisher Scientific, a major federal supplier of scientific products and laboratory equipment registered in the System for Award Management since 2001, brings extensive experience delivering specialized reagents and testing solutions to defense and civilian agencies including the National Institutes of Health, Department of Veterans Affairs, and the FDA. The company currently maintains a significant Blanket Purchase Agreement with the Department of Veterans Affairs valued at $1.65 million for toxicology and drugs of abuse testing supplies, underscoring its established role as a critical vendor for federal scientific and medical supply requirements. This delivery order aligns with Fisher Scientific's core business focus on providing high-quality molecular biology reagents essential for research, diagnostics, and laboratory testing operations across federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/16/25 |